JAMES RAVITZ

Food and Drug Administration policy on chronic wound healing products Food and Drug Administration user fee policy H.R. 2430 and S. 934 (FDA Reauthorization Act of 2017), all provisions Indian Health Service policy on chronic wound healing products Federal research funding for wound healing products

Food and Drug Administration policy on chronic wound healing products Food and Drug Administration user fee policy S. 934 (Prescription Drug User Fee Amendments of 2017), all provisions H.R. 2430 (FDA Reauthorization Act of 2017), all provisions

Food and Drug Administration policy on chronic wound healing products H.R. 6 and H.R. 34 (21st Century Cures Act), all provisions, and Senate companion legislation generally S. 2689 (REGROW Act), all provisions

Food and Drug Administration policy on chronic wound healing products H.R. 6 (21st Century Cures Act), all provisions, and Senate companion legislation generally S. 2689 (REGROW Act), all provisions S. 2700 (FDA and NIH Workforce Authorities Modernization Act), Section 16, regarding FDA guidances

Food and Drug Administration policy on chronic wound healing products H.R. 6 and H.R. 34 (21st Century Cures Act), all provisions, and Senate companion legislation generally S. 2689 (REGROW Act), all provisions

Food and Drug Administration policy on chronic wound healing products H.R. 6 (21st Century Cures Act), all provisions, and Senate companion legislation generally S. 2689 (REGROW Act), all provisions S. 2700 (FDA and NIH Workforce Authorities Modernization Act), Section 16, regarding FDA guidances

Food and Drug Administration policy on chronic wound healing products H.R. 6 (21st Century Cures Act), all provisions, and Senate companion legislation generally S. 2689 (REGROW Act), all provisions

Food and Drug Administration policy on chronic wound healing products H.R. 6 (21st Century Cures Act), all provisions, and Senate companion legislation generally S. 2689 (REGROW Act), all provisions S. 2700 (FDA and NIH Workforce Authorities Modernization Act), Section 16, regarding FDA guidances

Food and Drug Administration policy on chronic wound healing products H.R. 6 and H.R. 34 (21st Century Cures Act), all provisions, and Senate companion legislation generally S. 2689 (REGROW Act), all provisions

Food and Drug Administration policy on chronic wound healing products H.R. 6 (21st Century Cures Act), all provisions, and Senate companion legislation generally S. 2689 (REGROW Act), all provisions

Food and Drug Administration policy on chronic wound healing products H.R. 6 (21st Century Cures Act), all provisions, and Senate companion legislation generally S. 2689 (REGROW Act), all provisions S. 2700 (FDA and NIH Workforce Authorities Modernization Act), Section 16, regarding FDA guidances

Food and Drug Administration policy on chronic wound healing products H.R. 6 (21st Century Cures Act), all provisions, and Senate companion legislation generally S. 2689 (REGROW Act), all provisions S. 2700 (FDA and NIH Workforce Authorities Modernization Act), Section 16, regarding FDA guidances

Food and Drug Administration policy on chronic wound healing products H.R. 6 (21st Century Cures Act), all provisions, and Senate companion legislation generally S. 2689 (REGROW Act), all provisions S. 2700 (FDA and NIH Workforce Authorities Modernization Act), Section 16, regarding FDA guidances

Food and Drug Administration policy on chronic wound healing products H.R. 6 (21st Century Cures Act), all provisions

Food and Drug Administration policy on chronic wound healing products H.R. 6 (21st Century Cures Act), all provisions

Food and Drug Administration policy on chronic wound healing products H.R. 6 (21st Century Cures Act), all provisions S. 1767 (Combination Product Regulatory Fairness Act of 2015), all provisions

Food and Drug Administration policy on chronic wound healing products H.R. 6 (21st Century Cures Act), all provisions S. 1767 (Combination Product Regulatory Fairness Act of 2015), all provisions

Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product Legislation regarding Medicare reimbursement for chronic wound healing product, including: H.R. 2810 (Medicare Patient Access and Quality Improvement Act of 2013), and S.1871 (SGR Repeal and Medicare Beneficiary Access Act of 2013)

Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product Legislation regarding Medicare reimbursement for chronic wound healing product, including: H.R. 2810 (Medicare Patient Access and Quality Improvement Act of 2013), H.R. 4302 (Protecting Access to Medicare Act of 2014), S.1871 (SGR Repeal and Medicare Beneficiary Access Act of 2013), S.2110 (Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014), and H.R. 4015(SGR Repeal and Medicare Provider Payment Modernization Act of 2014)

Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product Legislation regarding Medicare reimbursement for chronic wound healing product, including: H.R. 2810 (Medicare Patient Access and Quality Improvement Act of 2013), and S.1871 (SGR Repeal and Medicare Beneficiary Access Act of 2013)

Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product Legislation regarding Medicare reimbursement for chronic wound healing product, including: H.R. 2810 (Medicare Patient Access and Quality Improvement Act of 2013), H.R. 4302 (Protecting Access to Medicare Act of 2014), S.1871 (SGR Repeal and Medicare Beneficiary Access Act of 2013), S.2110 (Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014), and H.R. 4015(SGR Repeal and Medicare Provider Payment Modernization Act of 2014)

Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product Legislation regarding Medicare reimbursement for chronic wound healing product, including: H.R. 2810 (Medicare Patient Access and Quality Improvement Act of 2013), H.R. 4302 (Protecting Access to Medicare Act of 2014), S.1871 (SGR Repeal and Medicare Beneficiary Access Act of 2013), S.2110 (Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014), and H.R. 4015(SGR Repeal and Medicare Provider Payment Modernization Act of 2014)

Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product Legislation regarding Medicare reimbursement for chronic wound healing product, including: H.R. 2810 (Medicare Patient Access and Quality Improvement Act of 2013), H.R. 4302 (Protecting Access to Medicare Act of 2014), S.1871 (SGR Repeal and Medicare Beneficiary Access Act of 2013), S.2110 (Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014), and H.R. 4015(SGR Repeal and Medicare Provider Payment Modernization Act of 2014)

Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product Legislation regarding Medicare reimbursement for chronic wound healing product, including: H.R. 2810 (Medicare Patient Access and Quality Improvement Act of 2013), and S.1871 (SGR Repeal and Medicare Beneficiary Access Act of 2013)

Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product Legislation regarding Medicare reimbursement for chronic wound healing product, including: H.R. 2810 (Medicare Patient Access and Quality Improvement Act of 2013), and S.1871 (SGR Repeal and Medicare Beneficiary Access Act of 2013)

Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product Legislation regarding Medicare reimbursement for chronic wound healing product, including: H.R. 2810 (Medicare Patient Access and Quality Improvement Act of 2013), H.R. 4302 (Protecting Access to Medicare Act of 2014), S.1871 (SGR Repeal and Medicare Beneficiary Access Act of 2013), S.2110 (Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014), and H.R. 4015(SGR Repeal and Medicare Provider Payment Modernization Act of 2014)

Hospital Outpatient Prospective Payment System proposed regulations regarding reimbursement for chronic wound healing product H.R. 2810 (Medicare Patient Access and Quality Improvement Act of 2013) and related Senate bill regarding reimbursement for chronic wound healing product